Cognition and Disease Characteristics in Adult Onset Versus Late Onset Multiple Sclerosis

Overview

Journal Mult Scler

Publisher Sage Publications

Specialty Neurology

Date 2021 Aug 19

PMID 34410177

Citations 8

Authors

Rachel Butler Pagnotti

Le H Hua

Justin B Miller

Affiliations

Soon will be listed here.

Abstract

Background: Cognitive impairment is common sequelae of multiple sclerosis (MS); however, relatively little is known about cognitive impairment in late-onset multiple sclerosis (LOMS).

Objective: To investigate differences in disease characteristics and cognition in LOMS and adult-onset multiple sclerosis (AOMS) patients.

Methods: Archival medical records and neuropsychological evaluations from an MS specialty center were reviewed. Differences in disease characteristics between 53 LOMS and 124 AOMS were compared using chi-square or analysis of variance (ANOVA). To investigate differences in cognitive functioning, age-adjusted standardized scores were compared via analysis of covariance (ANCOVA), using cardiac risk factors and disease duration as covariates.

Results: Compared to AOMS, LOMS patients had significantly more cardiac risk factors, shorter disease duration, and shorter time to diagnosis. LOMS patients had similar Expanded Disability Status Scale scores as AOMS patients. LOMS patients demonstrated significantly more impairment on tasks of visual learning and memory, and working memory than AOMS patients.

Conclusion: Despite a shorter disease duration, LOMS and AOMS patients had similar levels of physical impairment. However, even after accounting for differences in disease duration and cardiac risk, LOMS patients showed a greater burden of cognitive impairment than AOMS patients, suggesting MS diagnosed later in life may progress faster due to the interaction between MS neuropathology and aging.

Citing Articles

The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases.

Sarallah R, Jahani S, Khaboushan A, Moaveni A, Amiri M, Zolbin M Brain Behav Immun Health. 2025; 43():100932.

PMID: 39834554 PMC: 11743895. DOI: 10.1016/j.bbih.2024.100932.

Incidence of late onset multiple sclerosis in Italy: a population-based study.

Cicero C, Chisari C, Salafica G, Lo Fermo S, Donzuso G, Maimone D Sci Rep. 2024; 14(1):29649.

PMID: 39609522 PMC: 11604969. DOI: 10.1038/s41598-024-81284-3.

The influence of menopause on multiple sclerosis.

Simonsen C, Flemmen H, Broch L, Myklebust H, Berg-Hansen P, Brunborg C Eur J Neurol. 2024; 32(1):e16566.

PMID: 39601490 PMC: 11625929. DOI: 10.1111/ene.16566.

Cognitive Impairment in Multiple Sclerosis: An Update on Assessment and Management.

Portaccio E, Amato M NeuroSci. 2024; 3(4):667-676.

PMID: 39483763 PMC: 11523737. DOI: 10.3390/neurosci3040048.

The ageing central nervous system in multiple sclerosis: the imaging perspective.

Filippi M, Preziosa P, Barkhof F, Ciccarelli O, Cossarizza A, De Stefano N Brain. 2024; 147(11):3665-3680.

PMID: 39045667 PMC: 11531849. DOI: 10.1093/brain/awae251.

References

Melrose R, Zahniser E, Wilkins S, Veliz J, Hasratian A, Sultzer D . Prefrontal working memory activity predicts episodic memory performance: A neuroimaging study. Behav Brain Res. 2019; 379:112307. DOI: 10.1016/j.bbr.2019.112307. View

Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H . Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. 2001; 57(5):853-7. DOI: 10.1212/wnl.57.5.853. View

Fernandez-Concepcion O . [Clinical-epidemiological characteristics of late onset multiple sclerosis]. Rev Neurol. 1998; 25(148):1863-6. View

DeLuca J, Chelune G, Tulsky D, Lengenfelder J, Chiaravalloti N . Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?. J Clin Exp Neuropsychol. 2004; 26(4):550-62. DOI: 10.1080/13803390490496641. View

Roohani P, Emiru T, Carpenter A, Luzzio C, Freeman J, Scarberry S . Late onset multiple sclerosis: Is it really late onset?. Mult Scler Relat Disord. 2015; 3(4):444-9. DOI: 10.1016/j.msard.2014.02.004. View

Kantarci O, Lebrun C, Siva A, Keegan M, Azevedo C, Inglese M . Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome. Ann Neurol. 2015; 79(2):288-94. DOI: 10.1002/ana.24564. View

Tettey P, Simpson Jr S, Taylor B, van der Mei I . Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci. 2014; 347(1-2):23-33. DOI: 10.1016/j.jns.2014.10.020. View

Mahad D, Trapp B, Lassmann H . Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015; 14(2):183-93. DOI: 10.1016/S1474-4422(14)70256-X. View

Benedict R, Zivadinov R . Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol. 2011; 7(6):332-42. DOI: 10.1038/nrneurol.2011.61. View

10.

Amato M, Zipoli V, Portaccio E . Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006; 245(1-2):41-6. DOI: 10.1016/j.jns.2005.08.019. View

11.

Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F . Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2016; 23(9):1258-1267. DOI: 10.1177/1352458516674367. View

12.

Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V . Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J Clin Med. 2020; 9(5). PMC: 7290335. DOI: 10.3390/jcm9051326. View

13.

Lotti C, Oliveira A, Bichuetti D, de Castro I, Oliveira E . Late onset multiple sclerosis: concerns in aging patients. Arq Neuropsiquiatr. 2017; 75(7):451-456. DOI: 10.1590/0004-282X20170070. View

14.

Tutuncu M, Tang J, Zeid N, Kale N, Crusan D, Atkinson E . Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2012; 19(2):188-98. PMC: 4029334. DOI: 10.1177/1352458512451510. View

15.

Martinelli V, Rodegher M, Moiola L, Comi G . Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. Neurol Sci. 2005; 25 Suppl 4:S350-5. DOI: 10.1007/s10072-004-0339-8. View

16.

Langdon D . Cognition in multiple sclerosis. Curr Opin Neurol. 2011; 24(3):244-9. DOI: 10.1097/WCO.0b013e328346a43b. View

17.

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

18.

Yaffe K, Petersen R, Lindquist K, Kramer J, Miller B . Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord. 2006; 22(4):312-9. DOI: 10.1159/000095427. View

19.

Leritz E, McGlinchey R, Kellison I, Rudolph J, Milberg W . Cardiovascular Disease Risk Factors and Cognition in the Elderly. Curr Cardiovasc Risk Rep. 2011; 5(5):407-412. PMC: 3245189. DOI: 10.1007/s12170-011-0189-x. View

20.

Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G . Multiple sclerosis after age 50. Neurology. 1983; 33(12):1537-44. DOI: 10.1212/wnl.33.12.1537. View